業績 (2017年以降) |
■論文
- Zhou X, Park KH, Yamazaki D , Lin PH, Nishi M, Ma Z, Qiu L, Murayama T, Zou X, Takeshima H, Zhou J, Ma J. TRIC-A Channel Maintains Store Calcium Handling by Interacting With Type 2 Ryanodine Receptor in Cardiac Muscle. Circulation Research. 2020 Feb 14;126(4):417-435.
- Nishimura A, Shimoda K, Tanaka T, Toyama T, Nishiyama K, Shinkai Y, Numaga-Tomita T, Yamazaki D , Kanda Y, Akaike T, Kumagai Y, Nishida M. Depolysulfidation of Drp1 induced by low-dose methylmercury exposure increases cardiac vulnerability to hemodynamic overload. Science Signaling. 2019 Jun 25;12(587).
- Sato C, Yamazaki D , Sato M, Takeshima H, Memtily N, Hatano Y, Tsukuba T, Sakai E. Calcium phosphate mineralization in bone tissues directly observed in aqueous liquid by atmospheric SEM (ASEM) without staining: microfluidics crystallization chamber and immuno-EM. Scientific Reports. 9, 7352, 2019.
- Yamada S, Yamazaki D , Kanda Y. 5-Fluorouracil inhibits neural differentiation via Mfn1/2 reduction in human induced pluripotent stem cells. Journal of Toxicological Science. 43, 727-734, 2018.
- Yamada S, Kubo Y, Yamazaki D , Sekino Y, Nomura Y, Yoshida S, Kanda Y. Tributyltin Inhibits Neural Induction of Human Induced Pluripotent Stem Cells. Scientific Reports. 8, 12155, 2018.
- Yamada S, Yamazaki D , Kanda Y. Silver nanoparticles inhibit neural induction in human induced pluripotent stem cells. Nanotoxicology, 12, 836-846, 2018.
- Yamazaki D , Kitaguchi T, Ishimura M, Taniguchi T, Yamanishi A, Saji D, Takahashi E, Oguchi M, Moriyama Y, Maeda S, Miyamoto K, Morimura K, Ohnaka H, Tashibu H, Sekino Y, Miyamoto N, Kanda Y. Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes. Journal of Pharmacological Sciences, 136, 249-256, 2018
- Yamada S, Kubo Y, Yamazaki D , Sekino Y, Kanda Y. Chlorpyrifos inhibits neural induction via Mfn1-mediated mitochondrial dysfunction in human induced pluripotent stem cells. Scientific Reports, 7, 40925, 2017.
- Ando H, Yoshinaga T, Yamamoto W, Asakura K, Uda T, Taniguchi T, Ojima A, Shinkyo R, Kikuchi K, Osada T, Hayashi S, Kasai C, Miyamoto N, Tashibu H, Yamazaki D , Sugiyama A, Kanda Y, Sawada K, Sekino Y. A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes. Journal of Pharmacological and Toxicological Methods, 84, 111-127, 2017.
■総説
- Parish ST, Aschner M, Casey W, Corvaro M, Embry MR, Fitzpatrick S, Kidd D, Kleinstreuer NC, Lima BS, Settivari RS, Wolf DC, Yamazaki D , Boobis A. An evaluation framework for new approach methodologies (NAMs) for human health safety assessment. Regulatory Toxicology and Pharmacology. 2020 Apr;112:104592.
- 青井 貴之、浅香勲、阿久津英憲、伊藤弓弦、片岡健、諫田泰成、小島肇、関野祐子、末盛博文、中川誠人、中村和昭、中村幸夫、藤井万紀子、古江-楠田美保、山崎大樹. 「多能性幹細胞培養の留意点」の提案. 組織培養研究 38, 135-143, 2019
- 佐塚文乃、山田茂、山崎大樹、諫田泰成. ヒトiPS細胞を用いた医薬品の副作用予測法の開発と国際標準化. 再生医療の開発戦略と最新研究事例集(第5章第3節), 273-282, 2019.
- Kanda Y, Yamazaki D , Osada T, Yoshinaga T, Sawada K. Development of torsadogenic risk assessment using human induced pluripotent stem cell-derived cardiomyocytes: Japan iPS Cardiac Safety Assessment (JiCSA) update. Journal of Pharmacological Sciences. 138, 233-239, 2018.
- 中村和昭、諫田泰成、山崎大樹、片岡 健、青井貴之、中川誠人、藤井万紀子、阿久津英憲、末盛博文、浅香 勲、中村幸夫、小島 肇、伊藤弓弦、関野祐子、古江-楠田美保. 「培養細胞の観察の基本原則」の提案. 組織培養研究. 37, 123-131, 2018.
- Pamies D, Bal-Price A, Simeonov A, Tagle D, Allen D, Gerhold D, Yin D, Pistollato F, Inutsuka T, Sullivan K, Stacey G, Salem H, Leist M, Daneshian M, Vemuri MC, McFarland R, Coecke S, Fitzpatrick SC, Lakshmipathy U, Mack A, Wang WB, Yamazaki D , Sekino Y, Kanda Y, Smirnova L, Hartung T. Good Cell Culture Practice for stem cells and stem-cell-derived models. ALTEX, 34, 95-132, 2017.
- 諫田泰成、中村和昭、山崎大樹、片岡健、青井貴之、中川誠人、藤井万紀子、阿久津英憲、末盛博文、浅香勲、中村幸夫、小島肇、関野祐子、古江-楠田美保. 「細胞培養における基本原則」の提案. 組織培養研究, 36, 13-19, 2017.
- 山崎大樹、諫田泰成、関野祐子. 多点電極システムを用いた細胞外電位記録法‐ヒトiPS心筋細胞および齧歯類神経細胞における医薬品・化学物質の作用解析‐ぶんせき, 7, 290-295, 2017.
- 諫田泰成、山崎大樹、関野祐子. ヒトiPS細胞由来心筋細胞を用いた新たな薬理試験法の開発. 日薬理誌, 149, 110-114, 2017.
|